<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Valiton V</dc:creator>
  <dc:creator>Graf D</dc:creator>
  <dc:creator>Pruvot E</dc:creator>
  <dc:creator>Carroz P</dc:creator>
  <dc:creator>Fromer M</dc:creator>
  <dc:creator>Bisch L</dc:creator>
  <dc:creator>Tran VN</dc:creator>
  <dc:creator>Cook S</dc:creator>
  <dc:creator>Scharf C</dc:creator>
  <dc:creator>Burri H</dc:creator>
  <dc:date>2019</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Aims
Leadless pacemakers are implanted in Switzerland since June 2015. Large worldwide registries have shown high implant success, low complication rates, and good electrical parameters up to 12 months' follow-up. However, data are scarce outside the investigational setting. The purpose of this study is to assess the real-world experience regarding clinical safety and efficacy of Micra TPS (transcatheter pacing system) leadless pacemakers.


Methods and results
Retrospective observational, multi-centre study designed to assess initial safety and efficacy of the Micra TPS in the Swiss Romande region. A total of 92 patients were included from four different centres with an implantation success rate of 97.8% (90 of 92). Thresholds were overall low at implantation (median 0.38 V/0.24 ms, ranging from 0.13 to 2.88 V/0.24 ms) and remained stable over 1-year follow-up. The perioperative serious adverse event rate was 6.5% in six patients which lead to prolonged hospitalization in five patients and death in one patient. In addition, three further major events (3.3%) occurred during an average follow-up of 1 year, requiring implantation of a standard transvenous pacemaker in two patients, and surgical explantation of the Micra TPS in one patient due to intractable ventricular tachycardia.


Conclusion
Leadless pacemakers are a valuable adjunct for treating selected patients requiring single-chamber pacing. However, in this initial experience, major complication rates were high (9.8%). The implant procedure requires proper training and should be performed in an adequate setting.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/149719</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1093/europace/euy195</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/30202950</dc:relation>
  <dc:source>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. - 2019</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Action Potentials</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Adult</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Aged</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Aged, 80 and over</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Arrhythmias, Cardiac</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Cardiac Catheterization</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Cardiac Pacing, Artificial</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Device Removal</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Equipment Design</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Heart Rate</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Male</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Middle Aged</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Pacemaker, Artificial</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Retrospective Studies</dc:subject>
  <dc:subject xmlns:ns17="xml" ns17:lang="en">Risk Factors</dc:subject>
  <dc:subject xmlns:ns18="xml" ns18:lang="en">Switzerland</dc:subject>
  <dc:subject xmlns:ns19="xml" ns19:lang="en">Time Factors</dc:subject>
  <dc:subject xmlns:ns20="xml" ns20:lang="en">Treatment Outcome</dc:subject>
  <dc:subject xmlns:ns21="xml" ns21:lang="en">Young Adult</dc:subject>
  <dc:title xmlns:ns22="xml" ns22:lang="en">Leadless pacing using the transcatheter pacing system (Micra TPS) in the real world: initial Swiss experience from the Romandie region.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
